This page has been fact checked by an experienced mesothelioma Patient Advocate. Sources of information are listed at the bottom of the article.
We make every attempt to keep our information accurate and up-to-date.
Please Contact Us with any questions or comments.
Dr. Gregory A. Otterson is a thoracic oncologist at the James Cancer Hospital in Columbus Ohio and clinical director of the Thoracic Oncology Disease specific Research Group at the Ohio State University Comprehensive Cancer Center – James. He specializes in the treatment of patients with thoracic malignancies, including malignant pleural mesothelioma, adenocarcinoma, and thymic cancers, with an interest in developing novel therapeutic approaches that provide better outcomes.
Dr. Otterson’s clinical interests include applying combinations of conventional cytotoxic chemotherapy, novel targeted agents, and immunotherapy to patients with early-stage or advanced disease. He values the ability to work as part of a truly multi-disciplinary team whose medical oncologists, thoracic surgeons, radiation oncologists, pulmonologists, pathologists, radiologists, pharmacists, nurses, nurse practitioners, and physician assistants collaborate to improve patients’ quality of life and develop effective therapies.
Education and Career
Dr. Otterson earned a bachelor of arts degree in Theology and graduated Summa cum Laude from Creighton University in Omaha, Nebraska. He earned his medical degree at Georgetown University School of Medicine in Washington, D.C., graduating cum laude, and then completed a fellowship in Medical Oncology in the Clinical Oncology Program at the National Cancer Institute in Bethesda, Maryland. He completed his internship and residency in Internal Medicine at Rush-Presbyterian-St. Luke’s Medical Center in Chicago, Illinois.
After completing his medical education, Dr. Otterson served as an Instructor in the Department of Internal Medicine at the Uniformed Services University of the Health Sciences in Bethesda and Lieutenant Commander of Public Health Service in the Research Officer’s Group of the National Institutes of Health.
Dr. Otterson is an attending physician in Solid Tumor Oncology at the James Cancer Hospital and Richard J. Solove Research Institute. He also holds the titles of Professor in the Department of Internal Medicine At Ohio State University Medical School, Associate Division Director for Education, and Associate Director for the Hematology and Medical Oncology Fellowship Program.
Board certified in Medical Oncology and Internal Medicine, Dr. Otterson is a member of the National Comprehensive Cancer Network’s Non-Small Cell Lung Cancer Panel and a cadre member of the CALGB Respiratory Core Committee.
Dr. Otterson is a member of the Translational Therapeutics Program at the Ohio State University Comprehensive Cancer Center. In his research for the program, he focuses on genetic and epigenetic changes in lung cancers. He also seeks to understand which patients will best respond to specific therapeutic maneuvers.
Dr. Otterson has co-authored many articles that have appeared in such well-respected professional journals as Clinical Lung Cancer, Cancer, Molecular Cancer, and Journal of Clinical Oncology.
- Fellow, American College of Physicians
- International Association for the Study of Lung Cancer Member, Cancer And Leukemia Group B
- American Association for Cancer Research
- American Society of Clinical Oncology
- American Association for the Advancement of Science
- American College of Physicians
Written by Terri Oppenheimer
Terri Oppenheimer has been writing about mesothelioma and asbestos topics for over ten years. She has a degree in English from the College of William and Mary. Terri’s experience as the head writer of our Mesothelioma.net news blog gives her a wealth of knowledge which she brings to all Mesothelioma.net articles she authors.
Page Edited by Patient Advocate Dave Foster
Dave has been a mesothelioma Patient Advocate for over 10 years. He consistently attends all major national and international mesothelioma meetings. In doing so, he is able to stay on top of the latest treatments, clinical trials, and research results. He also personally meets with mesothelioma patients and their families and connects them with the best medical specialists and legal representatives available.